Hepatitis C virus in sub-Saharan Africa: a long road to elimination
Document Type
Article
Department
Internal Medicine (East Africa)
Abstract
The development of direct-acting antivirals against hepatitis C virus (HCV) has transformed the treatment landscape and underpinned the WHO goal of HCV elimination by 2030. However, as of 2021, few countries remain on track to achieve this goal. Reliable data remain scarce, especially those on national plans for HCV elimination in many regions of the world and particularly in sub-Saharan Africa, which accounts for around 11 million of 71 million people estimated to be living with HCV.
Publication (Name of Journal)
The Lancet Gastroenterology & Hepatology
Recommended Citation
Shah, R.,
Agyei-Nkansah, A.,
Alikah, F.,
Asamoah-Akuoko, L.,
Bagou, Y. O.,
Dhiblawe, A.,
Ehichioya, D.,
Finch, P. J.,
Katsidzira, L.,
Opio, C.
(2021). Hepatitis C virus in sub-Saharan Africa: a long road to elimination. The Lancet Gastroenterology & Hepatology, 6(9), 693-694.
Available at:
https://ecommons.aku.edu/eastafrica_fhs_mc_intern_med/238